FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3203800488> ?p ?o ?g. }

• W3203800488 endingPage "1618" @default.
• W3203800488 startingPage "1608" @default.
• W3203800488 abstract "Chimeric antigen receptor T-cell (CAR-T) therapy has transformed treatment paradigms for relapsed/refractory (r/r) B-cell acute lymphoblastic leukemia (B-ALL) in children and younger adults. We performed a systematic review to investigate the published literature on efficacy and toxicity of CAR-T therapy in adults with r/r B-ALL. We searched MEDLINE, Embase, and the Cochrane Library for prospective interventional studies and included published studies of ≥5 patients with median age at enrollment of ≥18 years. Risk of bias was assessed with a modified Institute of Health Economics tool. A total of 2566 records were assessed; 16 studies involving 489 patients were included in the final analysis. The mean complete remission (CR) rate was 81% and the measurable residual disease (MRD)-negative remission rate was 81% at 4 weeks after CAR-T infusion. With median follow-up across studies of 24 months, the cumulative 12-month probabilities of progression-free survival (PFS) and overall survival (OS) were 37% (95% CI, 26-48) and 57% (95% CI, 49-65), respectively. Relapse occurred in 40.3% of cases; target antigen was retained in 73.2% of relapses. Across studies, any grade of cytokine release syndrome (CRS) occurred in 82% of patients (95% CI, 61-95) and grade 3 or higher CRS in 27% (95% CI, 18-36). Neurotoxicity of any grade occurred in 34% of patients (95% CI, 24-47) and grade 3 or higher in 14% (95% CI, 1-25). In summary, CAR-T therapy achieves high early remission rates in adults with r/r B-ALL and represents a significant improvement over traditional salvage chemotherapy. Relapses are common and durable response remains a challenge." @default.
• W3203800488 created "2021-10-11" @default.
• W3203800488 creator A5003368910 @default.
• W3203800488 creator A5015976318 @default.
• W3203800488 creator A5039722640 @default.
• W3203800488 creator A5047086634 @default.
• W3203800488 creator A5070152563 @default.
• W3203800488 creator A5088457656 @default.
• W3203800488 creator A5090729996 @default.
• W3203800488 date "2022-03-07" @default.
• W3203800488 modified "2023-10-18" @default.
• W3203800488 title "Chimeric antigen receptor T-cell therapy in adults with B-cell acute lymphoblastic leukemia" @default.
• W3203800488 cites W1881216623 @default.
• W3203800488 cites W2008009748 @default.
• W3203800488 cites W2082708772 @default.
• W3203800488 cites W2141019574 @default.
• W3203800488 cites W2161374186 @default.
• W3203800488 cites W2419639370 @default.
• W3203800488 cites W2516611622 @default.
• W3203800488 cites W2554580516 @default.
• W3203800488 cites W2561777634 @default.
• W3203800488 cites W2567362164 @default.
• W3203800488 cites W2591709377 @default.
• W3203800488 cites W2777439917 @default.
• W3203800488 cites W2787301955 @default.
• W3203800488 cites W2787621143 @default.
• W3203800488 cites W2793787928 @default.
• W3203800488 cites W2796537738 @default.
• W3203800488 cites W2808092337 @default.
• W3203800488 cites W2900494540 @default.
• W3203800488 cites W2905654445 @default.
• W3203800488 cites W2911504656 @default.
• W3203800488 cites W2962839079 @default.
• W3203800488 cites W2978795816 @default.
• W3203800488 cites W2982584762 @default.
• W3203800488 cites W2992389962 @default.
• W3203800488 cites W2996446615 @default.
• W3203800488 cites W3013056502 @default.
• W3203800488 cites W3014823961 @default.
• W3203800488 cites W3016733176 @default.
• W3203800488 cites W3043222210 @default.
• W3203800488 cites W3084282507 @default.
• W3203800488 cites W3088527073 @default.
• W3203800488 cites W3092979662 @default.
• W3203800488 cites W3094048574 @default.
• W3203800488 cites W3095459105 @default.
• W3203800488 cites W3095855647 @default.
• W3203800488 cites W3113194839 @default.
• W3203800488 cites W3118615836 @default.
• W3203800488 cites W3169193862 @default.
• W3203800488 doi "https://doi.org/10.1182/bloodadvances.2020003482" @default.
• W3203800488 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34610109" @default.
• W3203800488 hasPublicationYear "2022" @default.
• W3203800488 type Work @default.
• W3203800488 sameAs 3203800488 @default.
• W3203800488 citedByCount "14" @default.
• W3203800488 countsByYear W32038004882022 @default.
• W3203800488 countsByYear W32038004882023 @default.
• W3203800488 crossrefType "journal-article" @default.
• W3203800488 hasAuthorship W3203800488A5003368910 @default.
• W3203800488 hasAuthorship W3203800488A5015976318 @default.
• W3203800488 hasAuthorship W3203800488A5039722640 @default.
• W3203800488 hasAuthorship W3203800488A5047086634 @default.
• W3203800488 hasAuthorship W3203800488A5070152563 @default.
• W3203800488 hasAuthorship W3203800488A5088457656 @default.
• W3203800488 hasAuthorship W3203800488A5090729996 @default.
• W3203800488 hasBestOaLocation W32038004881 @default.
• W3203800488 hasConcept C121332964 @default.
• W3203800488 hasConcept C121608353 @default.
• W3203800488 hasConcept C126322002 @default.
• W3203800488 hasConcept C142424586 @default.
• W3203800488 hasConcept C2776478404 @default.
• W3203800488 hasConcept C2777701055 @default.
• W3203800488 hasConcept C2778461978 @default.
• W3203800488 hasConcept C2779823535 @default.
• W3203800488 hasConcept C2780850621 @default.
• W3203800488 hasConcept C3875195 @default.
• W3203800488 hasConcept C71924100 @default.
• W3203800488 hasConcept C87355193 @default.
• W3203800488 hasConcept C90924648 @default.
• W3203800488 hasConcept C95190672 @default.
• W3203800488 hasConceptScore W3203800488C121332964 @default.
• W3203800488 hasConceptScore W3203800488C121608353 @default.
• W3203800488 hasConceptScore W3203800488C126322002 @default.
• W3203800488 hasConceptScore W3203800488C142424586 @default.
• W3203800488 hasConceptScore W3203800488C2776478404 @default.
• W3203800488 hasConceptScore W3203800488C2777701055 @default.
• W3203800488 hasConceptScore W3203800488C2778461978 @default.
• W3203800488 hasConceptScore W3203800488C2779823535 @default.
• W3203800488 hasConceptScore W3203800488C2780850621 @default.
• W3203800488 hasConceptScore W3203800488C3875195 @default.
• W3203800488 hasConceptScore W3203800488C71924100 @default.
• W3203800488 hasConceptScore W3203800488C87355193 @default.
• W3203800488 hasConceptScore W3203800488C90924648 @default.
• W3203800488 hasConceptScore W3203800488C95190672 @default.
• W3203800488 hasIssue "5" @default.
• W3203800488 hasLocation W32038004881 @default.
• W3203800488 hasLocation W32038004882 @default.

• next